Febuxostat induced Stevens Johnson syndrome: A case report
<b>Background:</b> Febuxostat is a novel non-purine selective xanthine oxidase inhibitor with superior ability to lower serum urate levels than allopurinol.<b>Case Report:</b> We report a case of Stevens Johnson syndrome following febuxostat administration.<b>Conclusion:</b> This case report underlines the necessity of recognising this major mucocutaneous adverse reaction and the need for cautious medication usage.
Authors
- Deepti Chopra (ORCID: https://orcid.org/0000-0001-9769-7825)
- Jaspreet Kaur Sidhu (ORCID: https://orcid.org/0000-0002-4716-8949)
Institutions
- All India Institute of Medical Sciences (IN)
- Amrita Vishwa Vidyapeetham (IN)
Publication Details
- Journal
- International Journal of Risk & Safety in Medicine
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1177/09246479241292014
- Citations
- 2
- Primary Topic
- Gout, Hyperuricemia, Uric Acid
- Type
- article
- Field-Weighted Citation Impact
- 0.68